
Graft Versus Host Disease (Gvhd) Treatment Markets And Companies: Global Strategic Business Report 2025-2030
(MENAFN- GlobeNewsWire - Nasdaq) Pharmaceutical Investments in Novel Immunosuppressive Drugs and Biologics Have Expanded Treatment Choices Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment - Global Strategic …